Novocure

Novocure company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire and Chesterbrook, Pennsylvania. Additionally, Novocure has offices in Canada, Germany, Japan, Poland and Israel.

Company Details

Employees
1.43K
Founded
-
Address
Neuhofstrasse 21, Zug,switzerland 6340,switzerland
Phone
603-436-2809
Email
me****@****ure.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Zug, Switzerland
Looking for a particular Novocure employee's phone or email?

Novocure Questions

News

Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress - Business Wire

Novocure to Present New Research for Tumor Treating Fields (TTFields) Therapy at European Association of Neuro-Oncology (EANO) Meeting and the European Society for Medical Oncology (ESMO) Congress Business Wire

New Clinical Data: Revolutionary Cancer Therapy Cuts Pancreatic Cancer Pain by 47%, Delays Opioid Use - Stock Titan

New Clinical Data: Revolutionary Cancer Therapy Cuts Pancreatic Cancer Pain by 47%, Delays Opioid Use Stock Titan

Novocure to Report Third Quarter 2025 Financial Results - Business Wire

Novocure to Report Third Quarter 2025 Financial Results Business Wire

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer - Yahoo Finance

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer Yahoo Finance

Novocure Announces Upcoming Investor Events - Business Wire

Novocure Announces Upcoming Investor Events Business Wire

Tumor Treating Fields Extend OS for Patients With Locally Advanced Pancreatic Cancer - ASCO Daily News

Tumor Treating Fields Extend OS for Patients With Locally Advanced Pancreatic Cancer ASCO Daily News

Houlahan Tours Leading Cancer Treatment Development Facility Novocure, Meets with Malvern Employees - U.S. Representative Chrissy Houlahan (.gov)

Houlahan Tours Leading Cancer Treatment Development Facility Novocure, Meets with Malvern Employees U.S. Representative Chrissy Houlahan (.gov)

Novocure: Wearable Electric Therapy Increases Survival in Patients with Pancreatic Adenocarcinoma - 2 Minute Medicine

Novocure: Wearable Electric Therapy Increases Survival in Patients with Pancreatic Adenocarcinoma 2 Minute Medicine

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data - Frontiers

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data Frontiers

FDA Approves Optune Lua Device in NSCLC - AJMC

FDA Approves Optune Lua Device in NSCLC AJMC

Houlahan Tours Leading Cancer Treatment Development Facility Novocure, Meets with Malvern Employees - U.S. Representative Chrissy Houlahan (.gov)

Houlahan Tours Leading Cancer Treatment Development Facility Novocure, Meets with Malvern Employees U.S. Representative Chrissy Houlahan (.gov)

Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting - Business Wire

Novocure to Present Final Results from the Pivotal Phase 3 METIS Trial of its Tumor Treating Fields (TTFields) Therapy for Brain Metastases from Non-Small Cell Lung Cancer at 2025 ASTRO Annual Meeting Business Wire

Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain - Business Wire

Novocure Announces Coverage of Tumor Treating Fields (TTFields) Therapy for Patients with Newly Diagnosed Glioblastoma in Spain Business Wire

Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer - Business Wire

Novocure Submits Premarket Approval Application to FDA for Tumor Treating Fields Therapy in Locally Advanced Pancreatic Cancer Business Wire

Novocure Reports Second Quarter 2025 Financial Results - Business Wire

Novocure Reports Second Quarter 2025 Financial Results Business Wire

Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC) - Business Wire

Novocure’s Optune Lua® Receives Approval in Japan for the Treatment of Unresectable Advanced/Recurrent Non-Small Cell Lung Cancer (NSCLC) Business Wire

Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire

Results From the Phase 3 PANOVA-3 Trial of Novocure’s Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting Business Wire

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update - Business Wire

Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update Business Wire

Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada - Business Wire

Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada Business Wire

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer - Stock Titan

Novocure Highlights TTFields Therapy in Treatment of Non-Small Cell Lung Cancer at 2024 World Conference on Lung Cancer Stock Titan

Novocure Announces Planned CEO Transition - Business Wire

Novocure Announces Planned CEO Transition Business Wire

FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer - Business Wire

FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer Business Wire

Glioblastoma patient Mike Hugo teams up with Novocure to discuss his TTF treatment - Yahoo News

Glioblastoma patient Mike Hugo teams up with Novocure to discuss his TTF treatment Yahoo News

A father of two diagnosed with Glioblastoma, creates special video with his daughters - sponsored by Novocure - WCNC

A father of two diagnosed with Glioblastoma, creates special video with his daughters - sponsored by Novocure WCNC

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer - Business Wire

Novocure Announces Update on Phase 3 Pivotal LUNAR Trial of Tumor Treating Fields in Non-Small Cell Lung Cancer Business Wire

Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation - Business Wire

Novocure Founder Yoram Palti Wins 2022 Israel Prize in Entrepreneurship and Technological Innovation Business Wire

Novocure Announces 15 Presentations at ASTRO21 - Imaging Technology News

Novocure Announces 15 Presentations at ASTRO21 Imaging Technology News

Carving a path ahead for glioblastoma, an aggressive brain cancer - statnews.com

Carving a path ahead for glioblastoma, an aggressive brain cancer statnews.com

Medicare panel gives equivocal backing to Novocure’s brain cancer device - medtechdive.com

Medicare panel gives equivocal backing to Novocure’s brain cancer device medtechdive.com

GenesisCare becomes first UK private cancer care provider to offer Optune Gio® - GenesisCare

GenesisCare becomes first UK private cancer care provider to offer Optune Gio® GenesisCare

Novocure Receives IDE Approval to Initiate METIS Trial - Imaging Technology News

Novocure Receives IDE Approval to Initiate METIS Trial Imaging Technology News

TTFields effektivt vid behandling av metastaser i hjärnan | Novocure Sverige - Mynewsdesk

TTFields effektivt vid behandling av metastaser i hjärnan | Novocure Sverige Mynewsdesk

Novocure presents novel anti-cancer hat for brain tumour patients - Innovation in Textiles

Novocure presents novel anti-cancer hat for brain tumour patients Innovation in Textiles

Positiva data vid pankreascancer. Novocures fas III-studie PANOVA-3 visar signifikant förlängd överlevnad vid behandling med Tumor Treating Fields (TTFields) och standardterapi - Mynewsdesk

Positiva data vid pankreascancer. Novocures fas III-studie PANOVA-3 visar signifikant förlängd överlevnad vid behandling med Tumor Treating Fields (TTFields) och standardterapi Mynewsdesk

Längre tid med Optune förlänger överlevnad vid glioblastom - Mynewsdesk

Längre tid med Optune förlänger överlevnad vid glioblastom Mynewsdesk

Top Novocure Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant